Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Am J Pharm Educ ; 88(3): 100674, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38360186

RESUMEN

OBJECTIVE: To assess the impact of student pharmacist state anxiety on vasopressor calculation accuracy in advanced cardiac life support (ACLS) simulations. METHODS: Third-year professional students participated in 2 ACLS-related simulation laboratory sessions. In week 1, students completed 3 calculations at their workstation with no stressors. Students were then randomized into teams for a bedside simulation where they independently completed 3 additional calculations either with or without stressors. Team assignments were maintained for week 2 where all participants completed a high-fidelity ACLS simulation that included a team vasopressor calculation. At both encounters, calculation accuracy was assessed as well as pre- and post-state anxiety using the Spielberger State-Trait Anxiety Inventory (STAI) survey tool. RESULTS: Students' (N = 145) trait anxiety aligned with normative data for similarly aged professional students. Post-simulation state anxiety in week 1 was found to be higher for those completing the activity with stressors than without (STAI score 44.7 vs 36.9) paired with lower bedside calculation accuracy, despite similar initial workstation calculation accuracy. In week 2, pre-simulation state anxiety score and calculation accuracy were not significantly different between the 2 groups. However, the state anxiety score significantly increased post-simulation for those exposed to stress in the previous week. CONCLUSION: Stress negatively impacted student pharmacist vasopressor calculation accuracy. However, the repeated exposure to a stressed simulation did not result in a significant difference in pre- or post-simulation state anxiety score or calculation accuracy when compared to a non-stressed control. Consideration should be made whether to include more "real-life" simulations in student pharmacist education.


Asunto(s)
Apoyo Vital Cardíaco Avanzado , Educación en Farmacia , Humanos , Anciano , Apoyo Vital Cardíaco Avanzado/educación , Farmacéuticos , Evaluación Educacional , Competencia Clínica , Ansiedad , Estudiantes
2.
Sr Care Pharm ; 36(11): 530-531, 2021 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-34717783
3.
Sr Care Pharm ; 36(4): 176-186, 2021 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-33766190

RESUMEN

Five new drugs marketed within the last year that are used for medical problems often experienced by older people have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating (NDCR) system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs considered include new agents indicated for the treatment of patients with hypercholesterolemia, Parkinson's disease, insomnia, schizophrenia, and age-related macular degeneration.


Asunto(s)
Aprobación de Drogas , Geriatría , Preparaciones Farmacéuticas , Anciano , Anciano de 80 o más Años , Humanos
4.
Curr Pharm Teach Learn ; 12(8): 975-980, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32565000

RESUMEN

BACKGROUND AND PURPOSE: Basic life support (BLS) and advanced cardiac life support (ACLS) skills performance, as well as simulated patient survival, were compared for student pharmacist teams with and without at least one member with American Heart Association (AHA) ACLS certification. EDUCATIONAL ACTIVITY AND SETTING: Doctor of pharmacy students in their third professional year completed a high-fidelity mannequin simulation. Within the previous year, 30 of 184 students (16%) completed ACLS certification. Rapid response teams (n = 31) of five to six members were formed through random student assignment. Two AHA instructors recorded and assessed performance using a checklist adapted from the AHA's standardized forms for BLS and ACLS assessment. Teams with and without ACLS certified members were compared for skills performance and simulated patient survival (i.e. correct performance of all BLS and ACLS skills). FINDINGS: Teams with ACLS certified members (n = 21) were superior to teams without certified members (n = 10) for correct performance of all observed BLS and ACLS skills, including pulse assessment and medication selection for cardiovascular support. For teams who had ACLS certified members, simulated patient survival was 86% higher. The study groups did not differ in their ability to calculate a correct vasopressor infusion rate if warranted. SUMMARY: BLS and ACLS skills performance were improved by AHA ACLS certification. Additionally, simulated patient survival was improved for teams with students who had at least one ACLS certified member.


Asunto(s)
Apoyo Vital Cardíaco Avanzado , Farmacéuticos , Certificación , Humanos , Maniquíes , Estudiantes , Estados Unidos
5.
Sr Care Pharm ; 35(4): 151-161, 2020 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-32192564

RESUMEN

Five new drugs for medical problems often affecting older people and marketed in the United States in 2019 have been considered in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs considered include new agents indicated for the treatment of patients with Parkinson's disease, rheumatoid arthritis, chronic obstructive pulmonary disease, osteoporosis in postmenopausal women, and chronic idiopathic constipation.


Asunto(s)
Aprobación de Drogas , Estreñimiento , Humanos , Estados Unidos
6.
Sr Care Pharm ; 34(4): 230-242, 2019 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-30935445

RESUMEN

Five new drugs marketed in 2018 that are used for medical problems often experienced by the elderly have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs include two agents for type 2 diabetes mellitus, a drug for hyperkalemia, an antiviral agent for influenza, and a drug for the treatment of open-angle glaucoma and ocular hypertension.


Asunto(s)
Diabetes Mellitus Tipo 2 , Hipertensión Ocular , Aprobación de Drogas , Humanos
7.
Curr Pharm Teach Learn ; 10(6): 744-749, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-30025775

RESUMEN

BACKGROUND AND PURPOSE: Pharmacy students' performance and retention of Basic Life Support (BLS) skills were evaluated 120 days after completion of a peer-led BLS training program. EDUCATIONAL ACTIVITY AND SETTING: This was a single-center, parallel group, observational study. Doctor of pharmacy (PharmD) students in their third professional year completed a peer-led BLS training program (n = 148) and participated in a high-fidelity mannequin simulation activity 120 days later. Students were randomly assigned to rapid response teams (n = 24) of five to six members and the American Heart Association's standardized form for BLS assessment was used to assess BLS skills performance. The performance of skills was compared to that of students two years prior to the implementation of the peer-led BLS program. FINDINGS AND DISCUSSION: Students who received peer-led BLS training demonstrated retention of BLS skills 120 days after the BLS training program. The teams also displayed significant improvement of the skills evaluated when compared to student teams prior to implementation of the peer-led training (n = 22). Improvement was demonstrated for assessment of responsiveness (96% vs. 41%, p < 0.001), assessment for breathing (100% vs. 32%, p < 0.001), assessment for pulse (96% vs. 36%, p < 0.001), and administration of appropriate ventilation (100% vs. 32%, p < 0.001). Numerical superiority was exhibited for high-quality cardiopulmonary resuscitation (CPR) initiation by teams who received peer-led training (100% vs. 86%, p = 0.101). SUMMARY: Students who received peer-led BLS training demonstrated significant improvement in BLS skills performance and retention 120 days after the training program. Data suggests that peer-led BLS training can improve student BLS skills performance and retention.


Asunto(s)
Competencia Clínica/normas , Evaluación Educacional/estadística & datos numéricos , Cuidados para Prolongación de la Vida/métodos , Retención en Psicología , Enseñanza/estadística & datos numéricos , Adulto , Evaluación Educacional/métodos , Femenino , Humanos , Masculino , Grupo Paritario , Estudiantes de Farmacia , Estados Unidos , Rendimiento Laboral
8.
Consult Pharm ; 33(4): 188-198, 2018 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-29609697

RESUMEN

Five new drugs marketed within the last year, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs include an anticoagulant, an antiparkinson agent, an agent for tardive dyskinesia, an agent for psoriasis, and an agent for constipation. The drugs reviewed are betrixaban, safinamide mesylate, valbenazine tosylate, guselkumab, and plecanatide.


Asunto(s)
Aprobación de Drogas , Anciano , Alanina/análogos & derivados , Alanina/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados , Anticoagulantes/uso terapéutico , Antiparkinsonianos/uso terapéutico , Benzamidas/uso terapéutico , Bencilaminas/uso terapéutico , Estreñimiento/tratamiento farmacológico , Humanos , Péptidos Natriuréticos/uso terapéutico , Psoriasis/tratamiento farmacológico , Piridinas/uso terapéutico , Discinesia Tardía/tratamiento farmacológico , Tetrabenazina/análogos & derivados , Tetrabenazina/uso terapéutico , Valina/análogos & derivados , Valina/uso terapéutico
9.
Consult Pharm ; 32(5): 258-268, 2017 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-28483006

RESUMEN

Five new drugs marketed within the last year that are used for medical problems often experienced by the elderly have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, an agent for gout, an antipsychotic agent, and a drug for dry eye disease.


Asunto(s)
Antiinflamatorios/uso terapéutico , Antipsicóticos/uso terapéutico , Drogas en Investigación/uso terapéutico , Supresores de la Gota/uso terapéutico , Hipoglucemiantes/uso terapéutico , Antiinflamatorios/efectos adversos , Antipsicóticos/efectos adversos , Drogas en Investigación/efectos adversos , Síndromes de Ojo Seco/tratamiento farmacológico , Supresores de la Gota/efectos adversos , Humanos , Hipoglucemiantes/efectos adversos , Insulina de Acción Prolongada/uso terapéutico , Péptidos/uso terapéutico , Fenilalanina/análogos & derivados , Fenilalanina/uso terapéutico , Piperidinas/uso terapéutico , Sulfonas/uso terapéutico , Tioglicolatos/uso terapéutico , Triazoles/uso terapéutico , Urea/análogos & derivados , Urea/uso terapéutico
10.
Am J Pharm Educ ; 79(1): 12, 2015 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-25741028

RESUMEN

OBJECTIVE: To assess pharmacy students' ability to retain advanced cardiac life support (ACLS) knowledge and skills within 120 days of previous high-fidelity mannequin simulation training. DESIGN: Students were randomly assigned to rapid response teams of 5-6. Skills in ACLS and mannequin survival were compared between teams some members of which had simulation training 120 days earlier and teams who had not had previous training. ASSESSMENT: A checklist was used to record and assess performance in the simulations. Teams with previous simulation training (n=10) demonstrated numerical superiority to teams without previous training (n=12) for 6 out of 8 (75%) ACLS skills observed, including time calculating accurate vasopressor infusion rate (83 sec vs 113 sec; p=0.01). Mannequin survival was 37% higher for teams who had previous simulation training, but this result was not significant (70% vs 33%; p=0.20). CONCLUSION: Teams with students who had previous simulation training demonstrated numerical superiority in ACLS knowledge and skill retention within 120 days of previous training compared to those who had no previous training. Future studies are needed to add to the current evidence of pharmacy students' and practicing pharmacists' ACLS knowledge and skill retention.


Asunto(s)
Apoyo Vital Cardíaco Avanzado/educación , Competencia Clínica , Educación en Farmacia , Estudiantes de Farmacia , Evaluación Educacional , Femenino , Equipo Hospitalario de Respuesta Rápida , Humanos , Masculino , Maniquíes
11.
Am J Pharm Educ ; 75(6): 113, 2011 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-21931451

RESUMEN

OBJECTIVE: To assess the impact of computer-based simulation on the achievement of student learning outcomes during mannequin-based simulation. DESIGN: Participants were randomly assigned to rapid response teams of 5-6 students and then teams were randomly assigned to either a group that completed either computer-based or mannequin-based simulation cases first. In both simulations, students used their critical thinking skills and selected interventions independent of facilitator input. ASSESSMENT: A predetermined rubric was used to record and assess students' performance in the mannequin-based simulations. Feedback and student performance scores were generated by the software in the computer-based simulations. More of the teams in the group that completed the computer-based simulation before completing the mannequin-based simulation achieved the primary outcome for the exercise, which was survival of the simulated patient (41.2% vs. 5.6%). The majority of students (>90%) recommended the continuation of simulation exercises in the course. Students in both groups felt the computer-based simulation should be completed prior to the mannequin-based simulation. CONCLUSION: The use of computer-based simulation prior to mannequin-based simulation improved the achievement of learning goals and outcomes. In addition to improving participants' skills, completing the computer-based simulation first may improve participants' confidence during the more real-life setting achieved in the mannequin-based simulation.


Asunto(s)
Educación en Farmacia/métodos , Aprendizaje , Maniquíes , Simulación de Paciente , Competencia Clínica , Simulación por Computador , Educación , Humanos , Estudiantes de Farmacia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA